Natural History of Untreated Retinoblastoma

Junyang Zhao1, Zhaoxun Feng2, Brenda L Gallie3,4,5,6

  • 1Department of Ophthalmology, Chongqing Aier Children's Eye Hospital, Chongqing 400020, China.

Cancers
|August 7, 2021
PubMed

Insights

Untreated retinoblastoma, a childhood eye cancer, progresses rapidly, leading to death within months. This study highlights the critical need for prompt diagnosis and treatment to prevent fatal outcomes in affected children.

Area of Science:

  • Ophthalmology
  • Pediatric Oncology
  • Cancer Research

Background:

  • Treatment abandonment is a primary cause of mortality in pediatric retinoblastoma globally.
  • Understanding the natural history of untreated retinoblastoma is crucial for emphasizing treatment urgency.

Purpose of the Study:

  • To delineate the natural history of retinoblastoma in children who abandoned treatment upfront at diagnosis.
  • To provide real-world evidence on the progression and survival rates of untreated retinoblastoma.

Main Methods:

  • Retrospective study of 44 children diagnosed with retinoblastoma between 2007-2017 across 29 Chinese centers who received no treatment.
  • Data collected via medical chart reviews and family interviews.
  • Analysis of clinical and radiologic evidence for orbital extension and systemic metastasis.

Main Results:

  • Median progression times: intraocular tumor to orbital disease (13.7 months), orbital disease to metastasis (2.6 months), metastasis to death (2.0 months).
  • Children with brain metastasis had significantly shorter survival (1.0 month) compared to other sites (3.1 months; p=0.015).
  • Mortality rates: 36% within 12 months, 77% within 24 months, 95% within 36 months, and 100% within 48 months of diagnosis.

Conclusions:

  • Untreated retinoblastoma follows a rapid and fatal natural history.
  • Real-world evidence underscores retinoblastoma's life-threatening nature, advocating for immediate treatment initiation upon diagnosis.
  • Informing clinicians and parents about these outcomes can improve treatment adherence and survival rates.